US 12,151,083 B2
Self-sealing septum
Thomas Kristen, Mannheim (DE); and Olaf Lebau, Mannheim (DE)
Assigned to Roche Diabetes Care, Inc., Indianapolis, IN (US)
Filed by Roche Diabetes Care, Inc., Indianapolis, IN (US)
Filed on Feb. 21, 2020, as Appl. No. 16/797,598.
Application 16/797,598 is a continuation of application No. PCT/EP2018/072330, filed on Aug. 17, 2018.
Claims priority of application No. 17187167 (EP), filed on Aug. 22, 2017; and application No. 17209081 (EP), filed on Dec. 20, 2017.
Prior Publication US 2020/0188582 A1, Jun. 18, 2020
Int. Cl. A61M 5/162 (2006.01); A61J 1/06 (2006.01); A61J 1/14 (2023.01); A61M 39/00 (2006.01); A61M 39/02 (2006.01)
CPC A61M 5/162 (2013.01) [A61M 39/0208 (2013.01); A61M 2039/0054 (2013.01); A61M 2039/0072 (2013.01); A61M 2039/0081 (2013.01)] 24 Claims
OG exemplary drawing
 
1. A pierceable elastic septum for use in drug reservoirs and infusion sets, comprising:
first and second surfaces positioned opposite to each other, wherein the first surface comprises a groove disposed around a center of the first surface and an outermost peripheral edge of the septum defines a total area bounded by the outermost peripheral edge wherein the second surface is a single planar surface that fills the entirety of the total area bounded by the outermost peripheral edge;
a varying distance between the first surface and the second surface configured such that when a higher pressure is applied to the first surface than the second surface, a component of a force exerted on the first surface acts towards an axis (A) which intersects the center of the first surface and a center of the second surface; and
a housing defining a compartment for a liquid drug wherein the septum is mounted on the housing in an unpierced condition with the first surface of the septum facing the compartment.